High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer

PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer. Currently, no effective treatment options for this condition exist. Nuclear factor erythroid 2-related factor 2 (NRF2), encoded by nuclear factor erythroid-derived 2-like 2 (NFE2L2) gene and its endogenous inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young Sub, Kang, Jun, Jung, Eun Sun, Lee, Ahwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625868/
https://www.ncbi.nlm.nih.gov/pubmed/37926068
http://dx.doi.org/10.4048/jbc.2023.26.e42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625868/
https://www.ncbi.nlm.nih.gov/pubmed/37926068
http://dx.doi.org/10.4048/jbc.2023.26.e42

Ejemplares similares